help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 36, No. 2 277-284
doi:10.1210/jcem-36-2-277
Copyright © 1973 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRIEGER, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KRIEGER, D. T.

Lack of Responsiveness to L-Dopa in Cushing's Disease1

DOROTHY T. KRIEGER

Neuroendocrine Laboratory, Division of Endocrinology of the Department of Medicine, Mount Sinai School of Medicine of the City University of New York

L-dopa was administered to 8 patients with Cushing's disease and the resultant response of plasma growth hormone (GH) and cortisol levels was evaluated. Cushing's disease in all patients was secondary to ACTH dependent bilateral adrenal hyperplasia. Four patients had clinically active disease, the four others were in clinical remission. Seven of these subjects failed to demonstrate any elevation in plasma growth hormone levels following L-dopa administration, which is a potent stimulus to growth hormone release in normal subjects. None of the patients showed any change in plasma cortisol levels following administration of L-dopa. These patients also manifested absent growth hormone responsiveness to insulin hypoglycemia, pitressin, and PiromenTM administration. Two of these patients received therapeutic doses of L-dopa for a 5- or 10-week period, in view of reported animal findings postulating a lack of central adrenergic inhibition in Cushing's disease. Neither patient showed any amelioration of the clinical or laboratory parameters of their disease.

1 Supported by Grants NB-02893 of the U.S. Public Health Service and U.S. Public Health Service Grant FR-71 from the Division of Research Facilities and Grants, and in part by a Grant from Hoffman La Roche.

Received July 12, 1972.




This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
N. J. Hopwood and F. M. Kenny
Incidence of Nelson's Syndrome After Adrenalectomy for Cushing's Disease in Children: Results of a Nationwide Survey
Arch Pediatr Adolesc Med, December 1, 1977; 131(12): 1353 - 1356.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1973 by The Endocrine Society